Literature DB >> 11757807

The parental phenotype of diabetes, but not of essential hypertension, is linked to the development of metabolic syndrome in Mexican individuals.

M Rodríguez-Morán1, F Guerrero-Romero.   

Abstract

Studies on the role of parental history on the risk of developing metabolic syndrome (MS) show inconsistent data that may depend on misclassification of the parental history. Confirming carefully the parental phenotype (PF) of type 2 diabetes mellitus (DM) and essential hypertension (EH) of participants' parents, we determined the relationship between PF of either DM or EH and the risk of developing MS in Mexican individuals. A case-control study of 210 subjects randomly recruited from Durango, Mexico was carried out. Subjects with MS (cases) were compared with a control group of subjects without MS matched by age and gender. MS was defined by the presence of two or more of the following: fasting glucose > or =7.0 mmol/l; blood pressure > or =160/90 mmHg; fasting triglycerides > or =1.7 mmol/l and/or HDL-cholesterol <1.0 mmol/l; and obesity (body mass index > or =30 kg/m2 and/or waist-to-hip ratio > or =0.85). The PF of DM and EH was confirmed by direct clinical examination and/or review of certificates of death of each of the participants' parents. Incomplete or unclear data about PH were exclusion criteria. Multivariate analysis showed that PF of DM without EH (odds ratio (OR) 2.6; 95% CI, 1.3-7.8, p=0.044) and PF of both DM and EH (OR, 3.1; 95% CI, 1.5-9.1, p=0.0001), but not the PF of EH without DM are independent predictors for developing MS in Mexican individuals. In the offspring generation of Mexican subjects, the PF of DM seems to increase the risk of developing MS, whereas PF of EH does not.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757807     DOI: 10.1007/s005920170019

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  Insulin resistance is independently related to age in Mexican women.

Authors:  M Rodríguez-Morán; F Guerrero-Romero
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

2.  Genome-wide linkage analysis of multiple metabolic factors: evidence of genetic heterogeneity.

Authors:  Ching-Yu Cheng; Kristine E Lee; Priya Duggal; Emily L Moore; Alexander F Wilson; Ronald Klein; Joan E Bailey-Wilson; Barbara E K Klein
Journal:  Obesity (Silver Spring)       Date:  2009-05-14       Impact factor: 5.002

3.  Clinical Characteristics of Type 2 Diabetes Patients according to Family History of Diabetes.

Authors:  Seung Uk Jeong; Dong Gu Kang; Dae Ho Lee; Kang Woo Lee; Dong-Mee Lim; Byung Joon Kim; Keun-Yong Park; Hyoun-Jung Chin; Gwanpyo Koh
Journal:  Korean Diabetes J       Date:  2010-08-31

Review 4.  Metabolic syndrome.

Authors:  Margo A Denke
Journal:  Curr Atheroscler Rep       Date:  2002-11       Impact factor: 5.113

5.  Glucose metabolism disorders in children with refractory nephrotic syndrome.

Authors:  Toshiyuki Takahashi; Takayuki Okamoto; Yasuyuki Sato; Asako Hayashi; Yasuhiro Ueda; Tadashi Ariga
Journal:  Pediatr Nephrol       Date:  2020-01-16       Impact factor: 3.714

6.  Comparison of the effects of sibling and parental history of type 2 diabetes on metabolic syndrome.

Authors:  Hsuan Chiu; Mei-Yueh Lee; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen; Jer-Ming Chang
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.